A study reveals that the majority of Chinese patients with hemophilia A depend on on-demand therapy, resulting in limited ...

Some people with hemophilia receive treatment to prevent bleeding, and other people with hemophilia are treated only when they are bleeding. Qfitlia (fitusiran) is a new hemophilia treatment to ...

Consider alternative treatment for hemophilia in patients with a history of symptomatic gallbladder disease. Serious thrombotic events have been reported in Qfitlia-treated patients. Thrombotic ...

J.R. Landry became one of only a handful in the nation, and the first in Rhode Island, to get what doctors believe will be ...

Subsequent studies by other investigators confirmed those early results, ultimately leading to the FDA approval of ...

In a 13-year follow-up by St. Jude Children’s Research Hospital and University College London published in The New England ...

Encouraged by the results of her most recent bone density scan, columnist G Shellye Horowitz pauses to celebrate the small ...

It was found that those with severe hemophilia B have less than 1% of normal factor IX activity, often experiencing spontaneous bleeding that can cause joint damage or life-threatening events.

A gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists ...